- Home
- AIRJ vs TKNO Comparison
AIRJ vs TKNO Comparison
Compare AIRJ & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRJ
- TKNO
- Stock Information
- Founded
- AIRJ N/A
- TKNO 1996
- Country
- AIRJ United States
- TKNO United States
- Employees
- AIRJ N/A
- TKNO N/A
- Industry
- AIRJ
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- AIRJ
- TKNO Health Care
- Exchange
- AIRJ NYSE
- TKNO Nasdaq
- Market Cap
- AIRJ 451.2M
- TKNO 430.2M
- IPO Year
- AIRJ N/A
- TKNO 2021
- Fundamental
- Price
- AIRJ $8.11
- TKNO $9.49
- Analyst Decision
- AIRJ Strong Buy
- TKNO Buy
- Analyst Count
- AIRJ 1
- TKNO 2
- Target Price
- AIRJ $12.00
- TKNO $5.00
- AVG Volume (30 Days)
- AIRJ 62.9K
- TKNO 228.0K
- Earning Date
- AIRJ 02-26-2025
- TKNO 03-10-2025
- Dividend Yield
- AIRJ N/A
- TKNO N/A
- EPS Growth
- AIRJ N/A
- TKNO N/A
- EPS
- AIRJ 4.07
- TKNO N/A
- Revenue
- AIRJ N/A
- TKNO $36,347,000.00
- Revenue This Year
- AIRJ N/A
- TKNO $3.47
- Revenue Next Year
- AIRJ N/A
- TKNO $12.07
- P/E Ratio
- AIRJ $1.98
- TKNO N/A
- Revenue Growth
- AIRJ N/A
- TKNO N/A
- 52 Week Low
- AIRJ $4.94
- TKNO $1.16
- 52 Week High
- AIRJ $49.11
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- AIRJ 48.38
- TKNO 56.46
- Support Level
- AIRJ $7.22
- TKNO $7.74
- Resistance Level
- AIRJ $8.48
- TKNO $9.86
- Average True Range (ATR)
- AIRJ 0.63
- TKNO 0.85
- MACD
- AIRJ -0.03
- TKNO 0.07
- Stochastic Oscillator
- AIRJ 45.05
- TKNO 63.66
About AIRJ MONTANA TECHNOLOGIES CORP
AirJoule Technologies Corp is the developer of AirJoule, an atmospheric water harvesting technology that provides efficient and sustainable air dehumidification and pure water from air. AirJoule can also enable transformative HVAC products to help customers save money on their energy bills while reducing environmental impact.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.